Find Industry reports, Company profilesReportLinker a...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker and M...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
of 12

Nanobiotechnology: Applications and Global Markets

The total market for nanobiotechnology products is $19.3 billion in 2010 and is growing at a compound annual growth rate (CAGR) of 9% to reach a forecast market size of $29.7 billion by 2015.Medical applications, including drug delivery and microbicides, dominate today's market, with sales of $19.1 billion in 2010.� This market segment is growing at a compound annual growth rate (CAGR) of 8.7%, and is forecast to reach sales of $29 billion by 2015.In the R&D tools market, DNA sequencing is an emerging growth opportunity for nanotechnologies. This sector is valued at $63 million in 2010 and is expected to increase at a 37% compound annual growth rate (CAGR) to reach $305 million in 2015.STUDY GOALS AND OBJECTIVESBCC's goal for this study is to examine the status of current and emerging nanobiotechnologies and products and assess their worldwide growth potential over a 5-year period from 2010 to 2015.�We are particularly interested in characterizing the nanobiotechnology market for drug delivery, diagnostics, R&D tools, microbicides, and DNA sequencing applications.�A main focus of this report is drug delivery, where the majority of nanotechnology sales occur.Our main objective is to present a comprehensive analysis of what constitutes the state-of-the-art for nanotech-enabled life science products and what the current and future commercial potential is for each of the key market segments.REASONS FOR DOING THE STUDYNanotechnology is coming of age as a materials platform in multiple industries including the biotechnology industry.�The unique properties that nanomaterials provide enable value-added performance in a range of life science applications, from encapsulating and releasing drugs to biologic imaging.�At the same time, the drug industry is searching for ways to extend drugs coming off patent as well as to improve drug pharmacokinetics.�The diagnostics industry is seeking ways to better image molecular events to meet demand for new medicines.�Nanobiotechnology, representing a diverse range of applications and materials, is the result of these converging forces.�Several nanotechnology platforms are already established and providing significant revenues in drug delivery applications, as well as diagnostics, microbicides, and R&D tools.�Significant nanotechnology drug formats include polymer, liposomal, and nanocrystal drugs.�Diagnostic and microbicide formats include nanoparticles, quantum dots, and dendrimers.�Nanopore formats are emerging in third-generation DNA sequencing applications.�Given the emerging nature of this industry, it is timely to analyze the key trends, markets, and industry dynamics to provide a useful basis for decision-making.�INTENDED AUDIENCEWe have compiled a study of the main nanomaterials that will be important in the five major end-user segments.�We present the nanobiotechnologies and growth-driving forces, product types, key market applications, companies and alliances, future market potential, and product sales forecasts for the period 2009 through 2015.�We project the future use of nano-enabled products for the key end-use segments: R&D tools, drug delivery, diagnostics, microbicides, and DNA sequencing.�We also examine the changing industry dynamics, key nanomaterials and their applications, and markets.This study will be of particular interest to the companies in the following industries:�diagnostics, pharmaceuticals, biotechnology, nanomaterials, life sciences tools, biodefense, medical devices, polymers, DNA sequencing, and medical and biologic imaging materials.�It will also be of interest to manufacturers of quantum dots, dendrimers, nanoparticles, nanocrystals, nanopores, biochips, and polymer nanoparticles.�SCOPE OF REPORTThe study scope includes the major nanotechnology formats that are likely to become commercialized within the next 5 years.�Each technology format is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2010 through 2015.�
Published on: Mar 3, 2016
Source: www.slideshare.net


Transcripts - Nanobiotechnology: Applications and Global Markets

  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Nanobiotechnology: Applications and Global MarketsPublished on January 2011 Report SummaryThe total market for nanobiotechnology products is $19.3 billion in 2010 and is growing at a compound annual growth rate (CAGR) of9% to reach a forecast market size of $29.7 billion by 2015.Medical applications, including drug delivery and microbicides, dominate todays market, with sales of $19.1 billion in 2010. Thismarket segment is growing at a compound annual growth rate (CAGR) of 8.7%, and is forecast to reach sales of $29 billion by 2015.In the R&D tools market, DNA sequencing is an emerging growth opportunity for nanotechnologies. This sector is valued at $63million in 2010 and is expected to increase at a 37% compound annual growth rate (CAGR) to reach $305 million in 2015.STUDY GOALS AND OBJECTIVESBCCs goal for this study is to examine the status of current and emerging nanobiotechnologies and products and assess theirworldwide growth potential over a 5-year period from 2010 to 2015. We are particularly interested in characterizing thenanobiotechnology market for drug delivery, diagnostics, R&D tools, microbicides, and DNA sequencing applications. A main focus ofthis report is drug delivery, where the majority of nanotechnology sales occur.Our main objective is to present a comprehensive analysis of what constitutes the state-of-the-art for nanotech-enabled life scienceproducts and what the current and future commercial potential is for each of the key market segments.REASONS FOR DOING THE STUDYNanotechnology is coming of age as a materials platform in multiple industries including the biotechnology industry. The uniqueproperties that nanomaterials provide enable value-added performance in a range of life science applications, from encapsulating andreleasing drugs to biologic imaging. At the same time, the drug industry is searching for ways to extend drugs coming off patent aswell as to improve drug pharmacokinetics. The diagnostics industry is seeking ways to better image molecular events to meetdemand for new medicines. Nanobiotechnology, representing a diverse range of applications and materials, is the result of theseconverging forces.Several nanotechnology platforms are already established and providing significant revenues in drug delivery applications, as well asdiagnostics, microbicides, and R&D tools. Significant nanotechnology drug formats include polymer, liposomal, and nanocrystaldrugs. Diagnostic and microbicide formats include nanoparticles, quantum dots, and dendrimers. Nanopore formats are emerging inthird-generation DNA sequencing applications.Given the emerging nature of this industry, it is timely to analyze the key trends, markets, and industry dynamics to provide a usefulbasis for decision-making.INTENDED AUDIENCEWe have compiled a study of the main nanomaterials that will be important in the five major end-user segments. We present thenanobiotechnologies and growth-driving forces, product types, key market applications, companies and alliances, future marketNanobiotechnology: Applications and Global Markets (From Slideshare) Page 1/12
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!potential, and product sales forecasts for the period 2009 through 2015. We project the future use of nano-enabled products for thekey end-use segments: R&D tools, drug delivery, diagnostics, microbicides, and DNA sequencing.We also examine the changing industry dynamics, key nanomaterials and their applications, and markets.This study will be of particular interest to the companies in the following industries: diagnostics, pharmaceuticals, biotechnology,nanomaterials, life sciences tools, biodefense, medical devices, polymers, DNA sequencing, and medical and biologic imagingmaterials.It will also be of interest to manufacturers of quantum dots, dendrimers, nanoparticles, nanocrystals, nanopores, biochips, andpolymer nanoparticles.SCOPE OF REPORTThe study scope includes the major nanotechnology formats that are likely to become commercialized within the next 5 years. Eachtechnology format is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2010through 2015. Technology issues and market-driving forces are discussed.Influencing factors, including drug delivery needs, biologic imaging trends, industry structure, and patent trends, are also discussed.BCC examines nanobiotechnology companies and industry alliances, nanomaterial consumption by end-user industry, andmarket-driving forces. We profile 115 nanobiotechnology companies.METHODOLOGYBCC presents an analysis of each of the key market segments that will be commercially important during the next 5 years: researchtools, drug delivery, diagnostics, next-generation DNA sequencing, and microbicides.Based on our analysis, we evaluate the potential applications of nanomaterial platforms in each of the major market segments andforecast sales revenues for 2010 through 2015.For research tools and drug discovery and development, the study presents a forecast from 2010 through 2015 for each of theimportant nanomaterials and applications. For drug delivery, we forecast the market by nanomaterial and by clinical indication. Fordiagnostics, the report forecasts from 2010 through 2015 the demand by application, modality, and nanomaterial. For microbicides,the report forecasts from 2010 through 2015 the demand by application and nanomaterial. For DNA sequencing, the study forecastsmarket size by use and by sequencing generation. Finally, we forecast the overall nanobiotechnology market by geographical region.INFORMATION SOURCESBCC surveyed life science companies and research institutions to obtain data for this study. Included were research tool firms,diagnostics firms, drug firms, nanomaterials firms, and leading nanotechnology research institutions. In addition, we compiled datafrom secondary sources including industry, trade, and governmentANALYST CREDENTIALSJohn Bergin has written previous BCC Research biotechnology reports, titled Epigenomics: DNA Sequencing: EmergingTechnologies and Applications; Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global BiochipMarkets: Microarrays and Lab-on-a-Chip; RNA Interference in the Post-Genomics Era: Markets and Technologies; SyntheticNanobiotechnology: Applications and Global Markets (From Slideshare) Page 2/12
  • 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Biology: Emerging Global Markets; Biologic Imaging Reagents: Technologies and Global Markets. Mr. Bergin has held businessdevelopment, sales, and marketing positions with a Fortune 500 advanced materials company as well as executive managementpositions with a nanotechnology company. Mr. Bergin holds the following degrees: B.S. Chemistry, M.S. Biotechnology, and Mastersof Business Administration. Table of ContentChapter- 1: INTRODUCTION -- ComplimentarySTUDY GOALS AND OBJECTIVES 1REASONS FOR DOING THE STUDY 1INTENDED AUDIENCE 2SCOPE OF REPORT 2METHODOLOGY 2INFORMATION SOURCES 3ANALYST CREDENTIALS 3RELATED BCC REPORTS 3BCC ONLINE SERVICES 4DISCLAIMER 4Chapter-2: SUMMARYSUMMARY 5SUMMARY TABLE GLOBAL VALUE OF NANOBIOTECHNOLOGY MARKET, BY END USER, THROUGH 2015 ($ MILLIONS) 6SUMMARY FIGURE GLOBAL VALUE OF NANOBIOTECHNOLOGY MARKET, BY END USER, 2009- 2015 ($ MILLIONS) 6SUMMARY (CONTINUED) 7Chapter-3: OVERVIEWINTRODUCTION 8TABLE 1 SCOPE OF THIS REPORT 8MARKET POTENTIAL OF NANOBIOTECHNOLOGY 9TABLE 2 GLOBAL VALUE OF NANOBIOTECHNOLOGY MARKET, BY APPLICATION, THROUGH 2015 ($ MILLIONS) 9NANOBIOTECHNOLOGY GROWTH DRIVING FORCES 10TABLE 3 NANOBIOTECHNOLOGY MARKET GROWTH DRIVING FORCES 10NANOBIOTECHNOLOGY MATERIALS PLATFORMS 11TABLE 4 GLOBAL VALUE OF NANOBIOTECHNOLOGY MARKET, BY PLATFORM, THROUGH 2015 ($ MILLIONS) 11NANOBIOTECHNOLOGY PRODUCT LIFE CYCLE STATUS 12TABLE 5 LIFE CYCLE STATUS OF NANOMATERIALS 12NANOBIOTECHNOLOGY INDUSTRY 12TABLE 6 NANOBIOTECHNOLOGY INDUSTRY 13NANOBIOTECHNOLOGY INDUSTRY (CONTINUED) 14Chapter-4: NANOBIOTECHNOLOGIESNANOBIOTECHNOLOGY 15Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 3/12
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!TABLE 7 FEATURES OF NANOTECHNOLOGIES 15HISTORY OF NANOTECHNOLOGY 15TABLE 8 HISTORICAL TIMELINE OF NANOTECHNOLOGY, 1931- 2007 16NANOTECHNOLOGY VALUE CHAIN 17TABLE 9 VALUE CHAIN FOR NANOTECHNOLOGIES 18BIO-NANOMATERIALS 18OVERVIEW 18TABLE 10 NANOBIOTECHNOLOGY MATERIALS 18APPLICATIONS STATUS 19TABLE 11 NANOMATERIALS APPLICATIONS STATUS 19LIFE CYCLE STATUS 20TABLE 12 NANOMATERIALS LIFE CYCLE STATUS 21NANOPARTICLES 21NANOPARTICLES (CONTINUED) 22TABLE 13 NANOPARTICLES IN IMAGING APPLICATIONS 23QUANTUM DOTS 24TABLE 14 COMPARISON OF QUANTUM DOTS, FLUORESCENT DYES AND FLUORESCENT PROTEINS 25FIGURE 1 QUANTUM DOT SPECTRA 25FIGURE 2 FLUORESCENT DYE SPECTRA 26LIPOSOMES 27TABLE 15 LIPOSOME TYPES 28DENDRIMERS 28NANOPORES 29TECHNICAL FEASIBILITY OF NANOPORE SEQUENCING 30NANOCRYSTALS 31TABLE 16 ADVANTAGES OF NANOCRYSTAL DRUG TECHNOLOGY 32POLYMER STRUCTURES 33INTEGRATED NANOSTRUCTURES 33INTEGRATED NANOSTRUCTURES (CONTINUED) 34INTEGRATED NANOSTRUCTURES (CONTINUED) 35Chapter-5: NANOBIOTECHNOLOGY APPLICATIONSINTRODUCTION 36TABLE 17 NANOBIOTECHNOLOGY MATERIALS/APPLICATIONS MATRIX 36DRUG DELIVERY APPLICATIONS 37TABLE 18 BENEFITS OF IMPROVED DRUG DELIVERY 37TABLE 19 KEY NANOMATERIALS IN DRUG DELIVERY 38TABLE 20 NUMBER OF COMMERCIAL DRUGS USING NANOTECHNOLOGY, BY INDICATION, SEPTEMBER 2010 38TABLE 21 MARKETED NANO-BASED DRUGS, 2010 39TABLE 21 (CONTINUED) 40TABLE 22 STATUS OF AMPHOTERICIN B 41TARGETED DELIVERY 42TABLE 23 TARGETED VERSUS NONTARGETED DRUG DELIVERY 43SIRNA DRUG DELIVERY 43FIGURE 3 RNAI SYSTEMIC DELIVERY APPROACHES 44BIOLOGIC IMAGING APPLICATIONS 45TABLE 24 KEY BIOLOGIC IMAGING NANO-REAGENT TYPES 46Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 4/12
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!WHY NANOPARTICLES ARE IMPORTANT FOR IMAGING 47SUMMARY OF NANOPARTICLE IMAGING APPLICATIONS 48TABLE 25 NANOPARTICLES IN IMAGING APPLICATIONS 49In Vivo Imaging 49TABLE 26 NANOPARTICLE IN VIVO DIAGNOSTICS PIPELINE 50TABLE 26 (CONTINUED) 51In Vitro Imaging 52TABLE 27 NANOSPHERE IN VITRO DIAGNOSTICS REAGENTS PIPELINE 52Genomics, Proteomics and Cell Biology Imaging 53EMERGING APPLICATIONS OF IMAGING REAGENTS 53FIGURE 4 THREE COMPONENTS OF ADVANCED IMAGING REAGENT TECHNOLOGY 54ADVANCED IMAGING NANO-REAGENTS 55TABLE 28 EMERGING BIOLOGIC NANO-IMAGING REAGENT FUNCTIONS 55Dual Modality Reagents 55Multifunctional Reagents 56Multiplexed Reagents 57SEQUENCING APPLICATIONS 57TABLE 29 SEQUENCING KEY NANOMATERIALS 58TABLE 30 USE OF NANOMATERIALS, BY SEQUENCING PLATFORM 58SEQUENCING APPLICATIONS (CONTINUED) 59FIGURE 5 $1,000 GENOME PROGRAM AWARDS, BY TECHNOLOGY, 2007-2009 60RESEARCH TOOLS APPLICATIONS 61MICROBICIDE APPLICATIONS 61TABLE 31 APPLICATIONS OF NANOMATERIALS IN MICROBICIDES 62Chapter-6: NANOBIOTECHNOLOGY INDUSTRY STRUCTUREINDUSTRY OVERVIEW 63TABLE 32 NANOBIOTECHNOLOGY MATERIALS/APPLICATIONS MATRIX 63DRUG DELIVERY INDUSTRY 64TABLE 33 DRUG DELIVERY INDUSTRY POSITION, BY NANOMATERIAL 65TABLE 34 DRUG DELIVERY COMPETITOR POSITION 66TABLE 34 (CONTINUED) 67TABLE 34 (CONTINUED) 68TABLE 34 (CONTINUED) 69TABLE 35 COMPANIES SPECIALIZING IN DRUG DELIVERY OF BIOMOLECULES 69NANOPORE SEQUENCING INDUSTRY 70TABLE 36 SEQUENCING INSTRUMENT COMPETITORS, BY TECHNOLOGY 70TABLE 36 (CONTINUED) 71QUANTUM DOTS INDUSTRY 72TABLE 37 QUANTUM DOTS KEY COMPETITORS 72ACQUISITIONS AND STRATEGIC ALLIANCES 73TABLE 38 NANOBIOTECHNOLOGY INDUSTRY ACQUISITIONS, 2007-2010 74TABLE 39 NANOBIOTECHNOLOGY INDUSTRY STRATEGIC ALLIANCES, 2007-2010 75TABLE 39 (CONTINUED) 76ACQUISITIONS AND STRATEGIC (CONTINUED) 77ACQUISITIONS AND STRATEGIC (CONTINUED) 78Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 5/12
  • 6. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Chapter-7: NANOBIOTECHNOLOGY MARKETSMARKET GROWTH DRIVING FORCES 79TABLE 40 NANOBIOTECHNOLOGY MARKET GROWTH DRIVING FORCES 79TABLE 41 NANOBIOTECHNOLOGY PEER-REVIEWED PUBLICATIONS, 1990-2009 80NANOBIOTECHNOLOGY MARKET SUMMARY 81NANOPRODUCTS MARKETS BY PLATFORM 81TABLE 42 GLOBAL VALUE OF NANOBIOTECHNOLOGY MARKET, BY PLATFORM, THROUGH 2015 ($ MILLIONS) 81NANOPRODUCTS MARKETS BY APPLICATION 82TABLE 43 GLOBAL VALUE OF NANOBIOTECHNOLOGY MARKET, BY APPLICATION, THROUGH 2015 ($ MILLIONS) 83TABLE 44 GLOBAL VALUE OF RESEARCH TOOLS MARKET, BY APPLICATION, THROUGH 2015 ($ MILLIONS) 83TABLE 45 GLOBAL VALUE OF RESEARCH TOOLS MARKET, BY NANOPLATFORM, THROUGH 2015 ($ MILLIONS) 84DNA SEQUENCING MARKET 85TABLE 46 GLOBAL VALUE OF NANOBIOTECHNOLOGY SEQUENCING MARKET, THROUGH 2015 ($ MILLIONS) 85TABLE 47 GLOBAL VALUE OF SANGER AND NEXT-GENERATION NANO-ENABLED SAMPLE PREPARATION MARKET, BYSEQUENCING GENERATION, THROUGH 2015 ($ MILLIONS) 86TABLE 48 GLOBAL VALUE OF THE NANO-ENABLED NANOPORE SEQUENCING MARKET, BY PRODUCT TYPE, THROUGH2015 ($ MILLIONS) 86TABLE 49 GLOBAL VALUE OF THE NANO-ENABLED SEQUENCING MARKET, BY NANOPLATFORM, THROUGH 2015 ($MILLIONS) 87DIAGNOSTICS MARKET 88DIAGNOSTICS MARKET SUMMARY 88TABLE 50 GLOBAL VALUE OF THE NANO-ENABLED DIAGNOSTICS MARKET, BY APPLICATION, THROUGH 2015 ($MILLIONS) 88TABLE 51 GLOBAL VALUE OF THE NANO-ENABLED DIAGNOSTICS MARKET, BY MODALITY, THROUGH 2015 ($ MILLIONS)89Diagnostics Market Summary (Continued) 90TABLE 52 GLOBAL VALUE OF THE NANO-ENABLED DIAGNOSTICS MARKET, BY NANO-PLATFORM, THROUGH 2015 ($MILLIONS) 91MRI MARKET 91TABLE 53 GLOBAL VALUE OF THE NANO-ENABLED MRI DIAGNOSTICS MARKET, BY NANO-PLATFORM, THROUGH 2015 ($MILLIONS) 92IN VITRO DIAGNOSTICS MARKETS 93TABLE 54 GLOBAL VALUE OF THE NANO-ENABLED IN VITRO DIAGNOSTICS MARKET, BY ASSAY TYPE, THROUGH 2015 ($MILLIONS) 93TABLE 55 GLOBAL VALUE OF THE NANO-ENABLED IN VITRO DIAGNOSTICS MARKET, BY NANO-PLATFORM, THROUGH2015 ($ MILLIONS) 94IN VITRO DIAGNOSTICS NANOPARTICLES MARKETS 95TABLE 56 GLOBAL VALUE OF NANOPARTICLE IN VITRO DIAGNOSTICS, BY NANO-PLATFORM, THROUGH 2015 ($MILLIONS) 95TABLE 57 GLOBAL VALUE OF GOLD NANOPARTICLE IN VITRO DIAGNOSTICS, BY APPLICATION, THROUGH 2015 ($MILLIONS) 96MICROBICIDES MARKET 96TABLE 58 GLOBAL VALUE OF THE NANO-ENABLED MICROBICIDES MARKET, BY APPLICATION, THROUGH 2015 ($MILLIONS) 96FIGURE 6 BRANDED CONDOM MANUFACTURER WORLDWIDE MARKET SHARES, 2010 (%) 97FIGURE 6 (CONTINUED) 98TABLE 59 GLOBAL VALUE OF NANO-ENABLED MICROBICIDES MARKET, BY PLATFORM, THROUGH 2015 ($ MILLIONS) 98Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 6/12
  • 7. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!DRUG DELIVERY MARKET 99TABLE 60 GLOBAL VALUE OF DRUG DELIVERY NANOPRODUCTS MARKET, BY INDICATION, THROUGH 2015 ($ MILLIONS)100TABLE 61 GLOBAL VALUE OF THE NANO-ENABLED DRUG DELIVERY MARKET, BY TECHNOLOGY PLATFORM, THROUGH2015 ($ MILLIONS) 101TABLE 62 GLOBAL VALUE OF THE NANO-ENABLED CANCER DRUG DELIVERY MARKET, BY TECHNOLOGY PLATFORM,THROUGH 2015 ($ MILLIONS) 102TABLE 63 GLOBAL VALUE OF NANO-ENABLED CNS DRUG DELIVERY MARKET, BY TECHNOLOGY PLATFORM, THROUGH2015 ($ MILLIONS) 103TABLE 64 GLOBAL VALUE OF NANO-ENABLED ANTI-INFECTIVE DRUG DELIVERY MARKET, BY TECHNOLOGY PLATFORM,THROUGH 2015 ($ MILLIONS) 104TABLE 65 GLOBAL VALUE OF NANO-ENABLED LIPID DISORDER DRUG DELIVERY MARKET, BY TECHNOLOGY PLATFORM,THROUGH 2015 ($ MILLIONS) 105TABLE 66 GLOBAL VALUE OF NANO-ENABLED OTHER DRUG DELIVERY MARKET, BY TECHNOLOGY PLATFORM,THROUGH 2015 ($ MILLIONS) 106NANOBIOTECHNOLOGY MARKETS BY GEOGRAPHY 106TABLE 67 GLOBAL VALUE OF NANOBIOTECHNOLOGY MARKET, BY GEOGRAPHY, THROUGH 2015 ($ MILLIONS) 107Chapter-8: NANOBIOTECHNOLOGY PATENT STATUSNANOBIOTECHNOLOGY PATENTS BY GEOGRAPHY 108FIGURE 7 NUMBER OF NANOBIOTECHNOLOGY PATENTS BY GEOGRAPHY, 2000 TO SEPTEMBER 2010 108FIGURE 7 (CONTINUED) 109DRUG DELIVERY PATENTS 109FIGURE 8 NUMBER OF DRUG DELIVERY NANOBIOTECHNOLOGY PATENTS BY NANOMATERIAL PLATFORM, 2000 TOSEPTEMBER 2010 110FIGURE 9 NUMBER OF DRUG DELIVERY NANOBIOTECHNOLOGY PATENTS BY GEOGRAPHY, 2000 TO SEPTEMBER 2010(%) 111FIGURE 10 NUMBER OF LIPOSOMAL DRUG DELIVERY PATENTS BY GEOGRAPHY, 2000 TO 2010 112FIGURE 10 (CONTINUED) 113FIGURE 11 NUMBER OF NANOPARTICLE DRUG DELIVERY PATENTS BY GEOGRAPHY, 2000 TO SEPTEMBER 2010 113FIGURE 11 (CONTINUED) 114Chapter-9: COMPANY PROFILESABBOTT GMBH & CO. KG 115ABRAXIS BIOSCIENCE 115ACCESS PHARMACEUTICALS, INC. 116ACUSPHERE, INC. 117TABLE 68 ACUSPHERE PRODUCT PIPELINE 117TABLE 69 ACUSPHERE PATENT ESTATE 118ACRYMED, INC. 118AION DIAGNOSTICS 119ALNIS BIOSCIENCES INC. 120AMAG PHARMACEUTICALS, INC. 120TABLE 70 AMAG MOLECULAR IMAGING REAGENTS PIPELINE 121TABLE 71 AMAG MRI IMAGING REAGENTS MARKETING ALLIANCES 122AGILENT TECHNOLOGIES, INC. 122Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 7/12
  • 8. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!AGILENT TECHNOLOGIES, INC.(CONTINUED) 123ALLERGAN, INC. 124ALLTRACEL PHARMACEUTICALS, PLC 124ALPHA RX, INC. 125ANSON NANO-BIOTECHNOLOGY CO. LTD. 125APHIOS CORPORATION 125AQUANOVA AG 126ARMAGEN TECHNOLOGIES, INC. 126ARTIFICIAL CELL TECHNOLOGIES, INC. 126AZAYA THERAPEUTICS 127BASE4 INNOVATION LTD. 127BAXTER INTERNATIONAL INC. 128BBI INTERNATIONAL 128BILCARE LIMITED 129BIND BIOSCIENCES, INC. 129BIOALLIANCE PHARMA 130BIOCON 131BIODELIVERY SCIENCES INTERNATIONAL, INC. 131BIO-GATE AG 132BIONANOMATRIX, INC. 132BIOPHAN TECHNOLOGIES, INC. 133BIOSANTÉ PHARMACEUTICALS INC. 133BIO-SYNECTICS, INC. 134CALANDO PHARMACEUTICAL 134CAMURUS AB 135CAPSULUTION PHARMA AG 136CELSION CORPORATION 136TABLE 72 CELSION LIPOSOMAL PLATFORM STATUS 137CENTOCOR ORTHO BIOTECH INC. 137CERAMISPHERE PTY LTD 138CERULEAN PHARMA INC. 138CHEMICELL GMBH 139CRITITECH, INC. 139CSL BEHRING 140CYTIMMUNE SCIENCES, INC. 140DAMAGE PREVENTION CONCEPT 140DENDRITECH, INC. 141ELAN CORPORATION PLC 141ELECTRONIC BIO SCIENCES 142ENDOCYTE 143ENZON PHARMACEUTICALS 143EPITARGET AS 144EVIDENT TECHNOLOGIES 144EXILICA LIMITED 145FERROPHARM GMBH 145FLAMEL TECHNOLOGIES 146FRESNIUS KABI AG 146GE HEALTHCARE UK LTD. 147Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 8/12
  • 9. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!GILEAD SCIENCES, INC. 147GRACEWAY PHARMACEUTICALS, LLC 148HANA BIOSCIENCES, INC. 148HUMAN GENOME SCIENCES 148IMMUNOVACCINE 149INDIANA NANOTECH LLC 149INTERNATIONAL BUSINESS MACHINES CORP. 150JOHNSON & JOHNSON, INC. 150KEREOS, INC. 151TABLE 73 KEREOS IMAGING REAGENTS PIPELINE 152TABLE 74 KEREOS STRATEGIC ALLIANCES 153LABOPHARM INC. 153LIFECARE INNOVATIONS PVT. LTD. 154LIPLASOME PHARMA APS 154LIPOXEN 155LUNA NANOWORKS 156MARINA BIOTECH 157MINGYUAN MEDICARE DEVELOPMENT COMPANY LTD. 157MYMETICS S.A. 158NABSYS, INC. 158NANOBIO CHEMICALS INDIA PRIVATE LIMITED 159NANOBIOTIX 159NANOBIOSYM, INC. 160NANOCARRIER CO., LTD. 160NANOCO TECHNOLOGIES LTD. 161NANOCOPOEIA, INC. 162NANOCYTE INC. 162NANOPROBES, INC. 163NANOSPECTRA BIOSCIENCES, INC. 164NANOSPHERE, INC. 164NANOTOX 165NANOVECTOR, INC. 165NATCO PHARMA LIMITED 165NOVAVAX, INC. 166NOVOSOM AG 166NOVOZYMES BIOPHARMA US INC. 166OCTOPLUS N.V. 167OXFORD NANOPORE TECHNOLOGIES LTD. 167OXFORD NANOPORE TECHNOLOGIES LTD. (CONTINUED) 168OXONICA INC. 169PACIRA PHARMACEUTICALS 169PANACEA BIOTEC LTD. 170PCI BIOTECH AS 170SALVONA TECHNOLOGIES INC. 171SCHERING-PLOUGH 171SELAH TECHNOLOGIES, LLC 172SELECTA BIOSCIENCES 172SEQUENOM, INC. 173Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 9/12
  • 10. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!SEQUENOM, INC. (CONTINUED) 173SEQUENOM, INC. (CONTINUED) 174SEQUENOM, INC. (CONTINUED) 175SIEMENS AG 176SIGMA-TAU PHARMACEUTICALS, INC. 176SKYEPHARMA PLC 177SMITH & NEPHEW PLC 178SNOGG AS 178SOPHERION THERAPEUTICS, LLC 178STARPHARMA HOLDINGS LTD 179TABLE 75 STARPHARMA STRATEGIC ALLIANCES 180SUPRATEK PHARMA 181TEKMIRA PHARMACEUTICALS 181TEVA PHARMACEUTICALS 181UNIDYM, INC. 182VIVE NANO INC. 182Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 10/12
  • 11. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Nanobiotechnology: Applications and Global Markets Product Formats Please select the product formats and the quantity you require. 1 User License--USD 4 850.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 11/12
  • 12. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Nanobiotechnology: Applications and Global Markets (From Slideshare) Page 12/12

Related Documents